ArticleThe Journal of urology2024

Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.

Leander Van Neste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.